Confounding by contraindication in a nationwide cohort study of risk for death in patients taking ibopamine

Annals of Internal Medicine

Volumn 134, Issue 7, 2001, Pages 569-572

  Feenstra, H ^a   Grobbee, R E ^a   In't Veld, B A ^a   Stricker, B H Ch ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IBOPAMINE;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CONTRAINDICATION; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NETHERLANDS; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SYNCOPE; TREATMENT OUTCOME;

EID: 0035799399     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-134-7-200104030-00010     Document Type: Article

References (8)

1. Observational studies of drug safety
2. You cannot exclude the explanation you have not considered
3. Confounding and indication for treatment in evaluation of drug treatment for hypertension
4. Risk factors for mortality in users of ibopamine
5. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure
6. Mededeling van het College ter beoordeling van geneesmiddelen betreffende ibopamine (Inopamil)
7. Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research
8. Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: The Rotterdam elderly study